Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge ...
4.5 / 5 (6) |
1
|
The key hallmark of Parkinson's disease is a slowdown of movement caused by a cutoff in the supply of dopamine to the brain region responsible for coordinating movement. While scientists have understood this ...
4 / 5 (2) |
1
|
Antipsychotic drugs, used in the treatment of psychotic disorders involving severe delusions and hallucinations, have been studied for more than 70 years. Currently available antipsychotic drugs, however, only alleviate certain ...
not rated yet |
1
With a new insight into a model of Parkinson's disease, researchers from the University of Pennsylvania School of Veterinary Medicine have identified a novel target for mitigating some of the disease's toll on the brain.
5 / 5 (2) |
0
|
A study by Massachusetts General Hospital researchers adds further support to the possibility that increasing levels of the antioxidant urate may protect against Parkinson's disease. In their report published in PNAS Early ...
5 / 5 (1) |
1
|
(Medical Xpress)—To John Salamone, professor of psychology and longtime researcher of the brain chemical dopamine, scientific research can be very slow-moving.
4.9 / 5 (14) |
1
|
The hallmark of Parkinson's Disease is the uncertain gait and movement caused by the destructions of neurons producing the neurotransmitter dopamine.
not rated yet |
0
The Feinstein Institute for Medical Research announced today the submission of a New Drug Application to the US Food and Drug Administration (FDA) for the Fluorodopa F 18 positron emission tomography (PET) scan used to diagnose ...
not rated yet |
0
The feel-good hormone dopamine improves long-term memory. This is the finding of a team lead by Emrah Düzel, neuroscientist at the German Center for Neurodegenerative Diseases and the University of Magdeburg. The researchers ...
5 / 5 (1) |
0
|
Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time. Their research could lead to a better understanding of many brain disorders, from drug ...
not rated yet |
0
|
Although placebos have played a critical role in medicine and clinical research for more than 70 years, it has been a mystery why these inactive treatments help to alleviate symptoms in some patients – and not others. Now ...
4 / 5 (1) |
0
|
Dopamine is a neurotransmitter that is associated with emotions, movement, and the brain's pleasure and reward system. In the current issue of Advances in Neuroimmune Biology, investigators provide a broad overview of the ...
5 / 5 (1) |
0
|
Curbs on children's daily screen time and delaying the age at which they start "the world's favorite pastime" are urgently needed to stave off the risk of serious health and developmental problems, argues a leading psychologist ...
1 / 5 (1) |
0
(Medical Xpress)—A new study by scientists in the US has found that the opiate morphine and the stimulant cocaine act on the reward centers in the brain in different ways, contradicting previous theories ...
5 / 5 (5) |
0
|
Raising levels of the neurotransmitter dopamine in the frontal cortex of the brain significantly decreased impulsivity in healthy adults, in a study conducted by researchers at the Ernest Gallo Clinic and Research Center ...
3 / 5 (1) |
0
|
